Nuformix (FRA:1RT) Other Stockholders Equity: €3.90 Mil (As of Mar. 2026)


What is Nuformix Other Stockholders Equity?

Nuformix FRA:1RT Other Stockholders Equity is €3.90 Mil as of Mar. 2026. The stock has 1 warning sign investors should review.

Nuformix's Other Stockholders Equity for the quarter that ended in Mar. 2026 was €3.90 Mil.

Nuformix's quarterly Other Stockholders Equity increased from Mar. 2025 (€3.60 Mil) to Sep. 2025 (€3.90 Mil) and increased from Sep. 2025 (€3.90 Mil) to Mar. 2026 (€3.90 Mil).

Nuformix's annual Other Stockholders Equity declined from Mar. 2023 (€5.66 Mil) to Sep. 2024 (€3.59 Mil) but then increased from Sep. 2024 (€3.59 Mil) to Sep. 2025 (€3.90 Mil).

Nuformix Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Nuformix's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuformix Other Stockholders Equity Chart

Nuformix Annual Data
Trend Dec15 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Sep24 Sep25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.77 5.95 5.66 3.59 3.90

Nuformix Semi-Annual Data
Dec15 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.85 3.59 3.60 3.90 3.90

Nuformix Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €3.90 Mil mean?
Nuformix (FRA:1RT) has a Other Stockholders Equity of €3.90 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Nuformix and its competitors.
Is Nuformix's Other Stockholders Equity too high?
Nuformix's current Other Stockholders Equity is €3.90 Mil.
How does Nuformix's Other Stockholders Equity compare to VRTX and REGN?
Nuformix's Other Stockholders Equity of €3.90 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Nuformix and its competitors. Nuformix's current Other Stockholders Equity is €3.90 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nuformix stock overvalued right now?
Nuformix (FRA:1RT) has a current Other Stockholders Equity of €3.90 Mil. The current Other Stockholders Equity is €3.90 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Nuformix (FRA:1RT), the current Other Stockholders Equity is €3.90 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nuformix Business Description

Other Exchanges NFX:UK1RT:Germany
Address C/O Arch Law Limited, 8 Bishopsgate, Huckletree Bishopsgate, London, GBR, EC2N 4BQ
Nuformix PLC is a pharmaceutical development company. It operates in pharmaceutical development, targeting unmet medical needs in fibrosis and oncology through drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.